IMMU-47. RNA-NANOPARTICLE VACCINES ARE SAFE AND IMMUNOLOGICALLY ACTIVE IN CLIENT-OWNED CANINES WITH TERMINAL GLIOMAS

BACKGROUND: The lack of appropriate preclinical murine glioblastoma models limits comprehensive toxicity/efficacy evaluation of investigational agents. To overcome this challenge, we evaluated the safety and activity of a new immunotherapeutic technology that we have pioneered (composed of tumor mRN...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Carrera-Justiz, Sheila, Stover, Brian, Milner, Rowan, Weidert, Frances, Huang, Jianping, Mitchell, Duane, Mendez-Gomez, Hector, Sayour, Elias
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
Immunology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847721/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.539
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍